Overview

Recent News

Date	Title and Summary
Toggle Summary Sep 30, 2019	Assertio Therapeutics Announces Appointment of Dr. David Wheadon to its Board of Directors LAKE FOREST, Ill. , Sept. 30, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) announced today that Dr. David Wheadon has been appointed to the Company’s Board of Directors. Dr. Wheadon is a former senior executive of AstraZeneca plc .
Toggle Summary Sep 26, 2019	Assertio Therapeutics to Present at the Annual Cantor Fitzgerald Global Healthcare Conference LAKE FOREST, Ill. , Sept. 26, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the Annual Cantor Fitzgerald Global Healthcare Conference in a session scheduled for 12:35 p.m.
Toggle Summary Aug 20, 2019	Assertio Therapeutics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference LAKE FOREST, Illinois , Aug. 20, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the 17 th Annual Morgan Stanley Global Healthcare Conference in a session scheduled for 11:45 a.m.

Filing date	Description	Form	Filing Group	View
Aug 15, 2018	8-K12B	8-K12B	Other	View HTML 0001104659-18-052087.pdf 0001104659-18-052087.rtf 0001104659-18-052087.xls
Mar 29, 2002	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	Proxy Filings	View HTML 0000912057-02-012655.pdf 0000912057-02-012655.rtf 0000912057-02-012655.xls
Mar 25, 2015	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	Proxy Filings	View HTML 0001047469-15-002712.pdf 0001047469-15-002712.rtf 0001047469-15-002712.xls
Apr 05, 2016	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	Proxy Filings	View HTML 0001047469-16-011902.pdf 0001047469-16-011902.rtf 0001047469-16-011902.xls
Mar 16, 2018	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	Proxy Filings	View HTML 0001047469-18-001778.pdf 0001047469-18-001778.rtf 0001047469-18-001778.xls

Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
Phone: 800.509.5586
http://www.continentalstock.com

Ernst & Young LLP
Palo Alto, CA

John B. Thomas
SVP, Investor Relations & Corporate Communications
jthomas@assertiotx.com